SEC FORM 4
—
Moleculin Biotech, Inc. (MBRX)
Acquisition (code M) of 207,500 shares; price not stated (see filing).
Reporting Person KLEMP WALTER V · Officer Title CEO and President · Transaction Code M
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001437749-26-032865 · filed 2026-10-16 · View filing →